Craft

QuidelOrtho

Stock Price

$38.4

2024-10-29

Market Capitalization

$2.6 B

2024-10-29

Revenue

$3 B

FY, 2023

QuidelOrtho Summary

Company Summary

Overview
QuidelOrtho is a developer and manufacturer of intelligent diagnostic solutions. It specializes in immunoassay, molecular testing, clinical chemistry, and transfusion medicine. The company offers specimen collection devices, clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation, immunohematology analyzers, lateral-flow pregnancy test strips, antigen diagnostic tests for Influenza A and Influenza B, tests for the detection of antibodies against HIV and hepatitis C, and other products. QuidelOrtho serves hospitals, hospital networks, clinical laboratories, and blood banks.
Type
Public
Status
Active
Founded
2022
HQ
San Diego, CA, US | view all locations
Website
https://www.quidelortho.com/
Cybersecurity rating
Sectors

Key People

  • Michael S. Iskra

    Michael S. Iskra, Executive Vice President and Chief Commercial Officer

  • Louise Brandy

    Louise Brandy, Chief Information Officer

  • Robert J. Bujarski

    Robert J. Bujarski, Executive Vice President and Chief Operating Officer

  • Joseph M. Busky

    Joseph M. Busky, Chief Financial Officer

Operating MetricsView all

Countries

130

Q1, 2024

LocationsView all

1 location detected

  • San Diego, CA HQ

    United States

    9975 Summers Ridge Rd

QuidelOrtho Financials

Summary Financials

Revenue (Q3, 2024)
$727.1M
Net income (Q3, 2024)
($19.9M)
Cash (Q3, 2024)
$143.7M
EBIT (Q3, 2024)
$15.0M
Enterprise value
$5.0B

Footer menu